{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:39:39Z","timestamp":1789061979500,"version":"build-2803163510"},"reference-count":30,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"Research Support Project for Pharmacoeconomics and Health Technology Evaluation of Zhejiang Provincial Pharmaceutical Association","award":["2022ZYJ21"],"award-info":[{"award-number":["2022ZYJ21"]}]},{"name":"Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2019KY448"],"award-info":[{"award-number":["2019KY448"]}]},{"name":"A Project Supported by Scientific Research Fund of Zhejiang Provincial Education Department","award":["Y202250087"],"award-info":[{"award-number":["Y202250087"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2024,10,20]]},"DOI":"10.1080\/14737167.2023.2288683","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T14:51:36Z","timestamp":1700837496000},"page":"1089-1096","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["A Markov model-based cost-effectiveness analysis comparing zanubrutinib to ibrutinib for treating relapsed and refractory chronic lymphocytic leukemia"],"prefix":"10.1080","volume":"24","author":[{"given":"Rongqi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjiang","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Department of Pharmacy, Zhejiang University of Traditional Chinese Medicine Affiliated Wenzhou Hospital, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziye","family":"Zhou","sequence":"additional","affiliation":[{"name":"Clinical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.1946"},{"issue":"11","key":"e_1_3_6_3_1","first-page":"56","article-title":"Annual economic burden of chronic lymphocytic leukemia in China","volume":"11","author":"Zhu S","year":"2018","unstructured":"Zhu S, Du L, Tao L, et al. Annual economic burden of chronic lymphocytic leukemia in China. China Health Insurance. 2018;11(11):56\u201362.","journal-title":"China Health Insurance"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-021-00973-6"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34510"},{"issue":"6","key":"e_1_3_6_6_1","first-page":"403","article-title":"Action mechanism and application progress of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia","volume":"46","author":"Xia Y","year":"2022","unstructured":"Xia Y, Xu W. Action mechanism and application progress of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia. Prog Pharm Sci. 2022;46(6):403\u2013411.","journal-title":"Prog Pharm Sci"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.630942"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2020.56.8.3158047"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211582"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-023-00583-9"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.1351"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.09.016"},{"key":"e_1_3_6_13_1","unstructured":"National Comprehensive Cancer Network. Chronic lymphocytic leukemia (version 1.2023). [cited 2023 Apr 12]. Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cll.pdf"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-023-00586-6"},{"issue":"3","key":"e_1_3_6_16_1","first-page":"12","article-title":"Statistical bulletin on national economic and social development of the people\u2019s Republic of China in 2022","volume":"71","author":"National Bureau of Statistics of China","year":"2023","unstructured":"National Bureau of Statistics of China. Statistical bulletin on national economic and social development of the people\u2019s Republic of China in 2022. China Statistics 2023 Feb 28; 71(3):12\u201329.","journal-title":"China Statistics"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1405158"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08661-4"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01257-4"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-013-0123-9"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.987337"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0322"},{"key":"e_1_3_6_23_1","unstructured":"IBM Micromedex\u00ae Red Book. Ibm. [cited 2023 Apr 12]. Available from: http:\/\/www.micromedexsolutions.com."},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.04.001"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-50"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686768"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406207231168215"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14795"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.09.317"},{"key":"e_1_3_6_30_1","doi-asserted-by":"crossref","first-page":"469580231170729","DOI":"10.1177\/00469580231170729","article-title":"Promoting access to innovative anticancer medicines: a review of drug price and national reimbursement negotiation in China","volume":"60","author":"Mingge X","year":"2023","unstructured":"Mingge X, Jingyu W, Qi L, et al. Promoting access to innovative anticancer medicines: a review of drug price and national reimbursement negotiation in China. Inquiry. 2023 Jan;60:469580231170729","journal-title":"Inquiry"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2021.03.001"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2023.2288683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T10:29:46Z","timestamp":1729506586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2023.2288683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,10,20]]}},"alternative-id":["10.1080\/14737167.2023.2288683"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2023.2288683","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}